On November 6, 2023, Medicenna (TSX:MDNA.TO) (OTC:MDNAF) announced that updated results from the Phase 1/2 ABILITY (A Beta-only IL-2 ImmunoTherapY Study) trial of MDNA11 were presented at SITC. MDNA11 ...

On March 25, 2020, Medicenna Therapeutics Corp. (TSX:MDNA.TO) (OTC:MDNAF) announced encouraging results from the company’s preclinical studies on MDNA19, the lead ‘Superkine’ program. MDNA19 is a long ...

MDNA failed to report data from the fifth dosing cohort, of its phase 1/2 ABILITY study of MDNA11, in Q2'23 as expected. The company is instead presenting data from both the fifth and sixth cohorts of ...

Madonna is standing in front of a small room of beauty editors talking about her new skin care line MDNA Skin. "Are you nervous?" she asks all of us. We laugh, because of course we are. It's Madonna.

It wasn't always perfect, but it wasn't always bad,” Madonna sings on "Best Friend," a haunting slow jam from her 2012 album MDNA. The song is technically available only on the deluxe version of the ...

The average one-year price target for Medicenna Therapeutics (NASDAQ:MDNA) has been revised to 3.93 / share. This is an increase of 34.63% from the prior estimate of 2.92 dated August 31, 2023. The ...

If you are a Material Girl fan that has been patiently waiting for Madonna's MDNA Skin brand to be widely available for purchase, you will be handsomely rewarded. Women's Wear Daily reports that ...

Medicenna Therapeutics Corp. Annual stock financials by MarketWatch. View the latest MDNA financial statements, income statements and financial ratios.